Clinical trial
A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)
NCT02130492 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)
- Lead sponsor
- Weill Medical College of Cornell University
- Phase
- Phase 1/2
- Overall status
- Suspended
- Start date
- May 31, 2014
- Completion date
- July 31, 2028
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
advanced cancer